 |
市場調査レポート
商品コード
1244303
静脈内輸液バッグの世界市場の規模、シェア、成長分析：輸液タイプ別、栄養素別 - 業界予測（2022年～2028年）Global Intravenous IV Fluid Bags Market Size, Share, Growth Analysis, By Fluid Type(Total Parenteral Nutrients, Peripheral Parenteral Nutrition), By Nutrients(Carbohydrates, Vitamins) - Industry Forecast 2022-2028 |
||||||
| 静脈内輸液バッグの世界市場の規模、シェア、成長分析：輸液タイプ別、栄養素別 - 業界予測（2022年～2028年） |
|
出版日: 2022年11月16日
発行: SkyQuest
ページ情報: 英文 165 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界の静脈内輸液バッグの市場規模は、2021年の17億米ドルから2028年までに34億9,000万米ドルに達し、予測期間（2022年～2028年）にCAGRで10.86%の成長が予測されています。高齢者人口が、市場の世界的な成長に寄与しています。
当レポートでは、世界の静脈内輸液バッグ市場について調査分析し、市場力学と見通し、セグメント分析、企業プロファイルなどを提供しています。
目次
エグゼクティブサマリー
調査手法
親市場の分析
主な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリックス
- パイプライン製品分析
- マクロ経済指標
- 主な投資の分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターのファイブフォース分析
- 将来の混乱に関する特別な考察
世界の静脈内輸液バッグ市場：輸液タイプ別
- 市場の概要
- 完全静脈栄養
- 末梢静脈栄養
世界の静脈内輸液バッグ市場：栄養素別
- 市場の概要
- 炭水化物
- ビタミン
- ミネラル
- 単回投与アミノ酸
- 非経口脂肪乳剤
- その他
世界の静脈内輸液バッグの市場規模：地域別
- 市場の概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
- ラテンアメリカ
- ブラジル
- その他のラテンアメリカ
- 中東・アフリカ
- GCC諸国
- 南アフリカ
- その他の中東・アフリカ
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主要市場企業が採用した戦略
- 主な成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Fresenius Kabi AG (Germany)
- Pfizer, Inc. (US)
- Otsuka Pharmaceutical Co., Ltd. (Japan)
- Baxter (US)
- B. Braun Melsungen AG (Germany)
- Vifor Pharma Management Ltd. (Switzerland)
- JW Life Science (South Korea)
- Amanta Healthcare (India)
- ICU Medical Inc. (US)
- Grifols, S.A. (Spain)
Global Intravenous IV Fluid Bags Market was valued at USD 1.7 billion in 2021 and it is expected to reach at USD 3.49 billion by 2028, at a CAGR of 10.86% over the forecast period (2022-2028).
Medical fluid bags are constructed of an internal pouch and an exterior plastic coating and available in a variety of sizes. Up until the projected expiration date printed on the bags, the fluids are safeguarded by the compartmentalization of these bags into an inner pouch and an exterior coating. These bags are widely used in medical facilities with a multipurpose approach to maintain adequate sterilised conditions for the blood samples that help in ensuring infection-free premises, limiting the spread of disease, and preventing any loss of blood samples or pharmaceuticals.These bags are also used in fluid replacement therapy, which ensures accurate body fluid collection, blood transfusions, correction of electrolyte imbalances, and maintenance of the patient's appropriate nutritional intake via an oral or enteral route of delivery.
End-users are using disposable IV fluid bags more frequently in an effort to reduce healthcare expenditures and avoid hospital acquired infections and cross-contamination. Also, they are gaining popularity at blood bank facilities in order to meet the demand for emergency blood infusions as well as to treat other blood-borne disorders. Furthermore, PVC-free bags composed of non-latex components are being manufactured by IV fluid bag producers to deliver IV fluids precisely and safely.
Moreover, bespoke combinations that are cold, frozen, or both can be kept in these fluid bags. As a result, the market is anticipated to expand in the next years as a result of both an increase in innovations and a growing preference for IV fluid bags over traditional IV bags.
Top-down and bottom-up approaches were used to estimate and validate the size of Asia Pacific Intravenous IV Fluid Bags Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Segments covered in this report
The global Intravenous IV fluid bags market is segmented based on fluid type, nutrient, and region. Based on fluid type, the market is segmented into total parenteral nutrition and peripheral parenteral nutrition. On the basis of nutrient, the market can be bifurcated into carbohydrates, vitamins and minerals, single dose amino acids, parenteral liquid emulsion segments. The regional insights of the market are into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa.
Driver
The older population is contributing to the global growth of the intravenous fluid bags market. Many disorders associated with ageing necessitate the adoption of efficient drug administration methods. Medications given intravenously are preferred to those given orally since the former results in more rapid and precise results. The preference for intravenous fluid administration is anticipated to increase with more consumer knowledge, and this will promote market expansion over the course of the anticipated period.
Restraint
The IV bag market may suffer as a result of the risk of infection and vein collapse brought on by the needle remaining in place for an extended period of time. Inadequate monitoring of intravenous therapy can potentially result in nutrient imbalances in the patient's body.
The availability of substitutes, such as plastic bottles, glass bottles, and infusion pumps to regulate the flow of solution into veins, may be a hindrance to the IV fluid bags industry. An electrolyte solution of this size, which is generally produced in IV bags of the customary 1 litre size, should not be introduced to children.
Market Trends
The rising prevalence of different chronic conditions, including diabetes, cancer, cardiovascular diseases, kidney infections, and liver disorders, is one of the key reasons driving the growth of the medical fluid bags market globally. A further factor driving industrial expansion is the rise in gastrointestinal illnesses, particularly in the senior population. Patients' health may be negatively impacted by the usage of PVC-based medical fluid bags, and the environment may suffer from incorrect disposal. The growth of the market can be slowed by these problems. The globalisation of hospitals and the healthcare sector, on the other hand, has led to a large rise in the usage of intravenous fluid bags.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Global Intravenous IV Fluid Bags Market by Fluid Type
- Market Overview
- Total Parenteral Nutrients
- Peripheral Parenteral Nutrition
- Global Intravenous IV Fluid Bags Market by Nutrients
- Market Overview
- Carbohydrates
- Vitamins
- Minerals
- Single Dose Amino Acids
- Parenteral Lipid Emulsion
- Others
- Global Intravenous IV Fluid Bags Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- Fresenius Kabi AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Pfizer, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Otsuka Pharmaceutical Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Baxter (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Vifor Pharma Management Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- JW Life Science (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Amanta Healthcare (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ICU Medical Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Grifols, S.A. (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
